CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers
Saved in:
| Other Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2014
|
| In: |
Clinical pharmacology & therapeutics
Year: 2014, Volume: 95, Issue: 3, Pages: 250-251 |
| ISSN: | 1532-6535 |
| DOI: | 10.1038/clpt.2013.188 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/clpt.2013.188 |
| Author Notes: | C. Markert, J. Burhenne, J. Weiss, G. Mikus and W. E. Haefeli |
| Item Description: | Gesehen am 23.02.2015 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1532-6535 |
| DOI: | 10.1038/clpt.2013.188 |